These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10565783)

  • 1. Forward cardiac output measurement with first-pass technique using 99mTc-labeled myocardial perfusion imaging agents.
    Taki J; Muramori A; Kinuya S; Nakajima K; Matsunari I; Miyazaki Y; Murata Y; Tonami N
    J Nucl Med; 1999 Nov; 40(11):1874-81. PubMed ID: 10565783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of cardiac output by first-pass data with technetium-99m-labeled myocardial perfusion imaging agent].
    Muramori A; Taki J; Kinuya S; Miyazaki Y; Nakajima K; Matsunari I; Tonami N
    Kaku Igaku; 1998 Jun; 35(5):273-9. PubMed ID: 9695460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction: comparison with equilibrium radionuclide angiography.
    Manrique A; Faraggi M; Véra P; Vilain D; Lebtahi R; Cribier A; Le Guludec D
    J Nucl Med; 1999 May; 40(5):805-9. PubMed ID: 10319754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography.
    Williams KA; Taillon LA
    J Am Coll Cardiol; 1996 Jan; 27(1):173-81. PubMed ID: 8522692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction.
    Gunning MG; Anagnostopoulos C; Davies G; Forbat SM; Ell PJ; Underwood SR
    J Nucl Med; 1997 Mar; 38(3):438-42. PubMed ID: 9074534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
    Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
    J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gated planar technetium 99m-labeled sestamibi myocardial perfusion image inversion for quantitative scintigraphic assessment of left ventricular function.
    Williams KA; Taillon LA
    J Nucl Cardiol; 1995; 2(4):285-95. PubMed ID: 9420802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P; Bossuyt A; Franken PR
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assessment of myocardial free fatty acid utilization and left ventricular function using 123I-BMIPP-gated SPECT.
    Inubushi M; Tadamura E; Kudoh T; Hattori N; Kubo S; Koshiji T; Nishimura K; Komeda M; Tamaki N; Konishi J
    J Nucl Med; 1999 Nov; 40(11):1840-7. PubMed ID: 10565779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?
    Tausig A; Knesewitsch P; Brinkbäumer K; Tatsch K; Hahn K
    Nucl Med Commun; 2000 Oct; 21(10):965-70. PubMed ID: 11130339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
    Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
    J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
    Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
    Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Tc-99m sestamibi first-pass radionuclide angiography and cardiac SPECT imaging during arbutamine infusion delivered by a computerized closed-loop system.
    Borges-Neto S; Curtis MA; Morris EI; Hanson MW; Coleman RE
    Clin Nucl Med; 1999 Jan; 24(1):42-7. PubMed ID: 9890492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
    Naruse H; Daher E; Sinusas A; Jain D; Natale D; Mattera J; Makuch R; Wackers FJ
    J Nucl Med; 1996 Nov; 37(11):1783-8. PubMed ID: 8917175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass radionuclide determination of cardiac output: an improved gamma camera method.
    Kelbaek H; Hartling OJ; Skagen K; Munck O; Henriksen O; Godtfredsen J
    J Nucl Med; 1987 Aug; 28(8):1330-4. PubMed ID: 3612293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part I. In vivo evaluation of 99mTc MIBI and 99mTc Tetrofosmin biophysical localization mechanisms.
    Stefanescu C; Rusu V; Boişteanu D; Azoicai D; Costin M; Oleniuc D; Hurjui M; Sattish P
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):944-9. PubMed ID: 17438905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validation of automatic quantitative defect size in rest technetium-99m-sestamibi myocardial perfusion SPECT.
    Kang X; Berman DS; Van Train KF; Amanullah AM; Areeda J; Friedman JD; Kiat H; Germano G
    J Nucl Med; 1997 Sep; 38(9):1441-6. PubMed ID: 9293805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: a European multicentre study.
    Bisi G; Sciagrà R; Büll U; Britton KE; Eilles C; Eissner D; Hahn K; Höffken H; Joseph K; McKillop JH
    Eur J Nucl Med; 1991; 18(3):178-83. PubMed ID: 1645664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.